Impaired surfactant production by alveolar epithelial cells in a SCID-hu lung mouse model of congenital human cytomegalovirus infection

Journal of Virology

Volumn 86, Issue 23, 2012, Pages 12795-12805

  Maidji, Ekaterina ^a   Kosikova, Galina ^a   Joshi, Pheroze ^a   Stoddart, Cheryl A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SURFACTANT; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONGENITAL INFECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; EPITHELIUM CELL; FETUS; GENE DOSAGE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNOHISTOCHEMISTRY; INOCULATION; LUNG ALVEOLUS EPITHELIUM; LUNG INFECTION; MALE; MESENCHYME CELL; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; VIRUS GENOME; VIRUS ISOLATION; VIRUS REPLICATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CYTOMEGALOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MICE; MICE, SCID; PULMONARY ALVEOLI; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; STATISTICS, NONPARAMETRIC; VIRAL PROTEINS; VIRUS REPLICATION;

ANIMALIA; HUMAN HERPESVIRUS 5; MUS;

EID: 84869219967     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01054-12     Document Type: Article

References (74)

1. Andreeva AV, Kutuzov MA, Voyno-Yasenetskaya TA. 2007. Regulation of surfactant secretion in alveolar type II cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 293, L259-L271. doi, 10.1152/ajplung.00112.2007.
2. Andreoni M, Faircloth M, Vugler L, Britt WJ. 1989. A rapid microneutralization assay for the measurement of neutralizing antibody reactive with human cytomegalovirus. J. Virol. Methods 23, 157-167.
3. Ballard RA, Drew WL, Hufnagle KG, Riedel PA. 1979. Acquired cytomegalovirus infection in preterm infants. Am. J. Dis. Child. 133, 482-485.
4. Balthesen M, Messerle M, Reddehase MJ. 1993. Lungs are a major organ site of cytomegalovirus latency and recurrence. J. Virol. 67, 5360-5366.
5. Bardales RH, Xie SS, Schaefer RF, Hsu SM. 1996. Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am. J. Pathol. 149, 845-852.
6. Betz P, et al. 1992. Determination of fetal age by immunohistochemical estimation of surfactant-producing alveolar type II cells. Forensic Sci. Int. 53, 193-202.
7. Bidanset DJ, Rybak RJ, Hartline CB, Kern ER. 2004. Efficacy of ganciclovir and cidofovir against human cytomegalovirus replication in SCID mice implanted with human retinal tissue. Antiviral Res. 63, 61-64.
8. Bissinger AL, Sinzger C, Kaiserling E, Jahn G. 2002. Human cytomegalovirus as a direct pathogen, correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease. J. Med. Virol. 67, 200-206.
9. Bravo FJ, Cardin RD, Bernstein DI. 2007. A model of human cytomegalovirus infection in severe combined immunodeficient mice. Antiviral Res. 76, 104-110.
10. Britt WJ. 2010. Human cytomegalovirus, propagation, quantification, and storage. Curr. Protoc. Microbiol. 14, 14E.13. doi, 10.1002/ 9780471729259.mc14e03s18.
11. Chakraborty M, McGreal EP, Kotecha S. 2010. Acute lung injury in preterm newborn infants, mechanisms and management. Paediatr. Respir. Rev. 11, 162-170.
12. Cheong JL, Cowan FM, Modi N. 2004. Gastrointestinal manifestations of postnatal cytomegalovirus infection in infants admitted to a neonatal intensive care unit over a five year period. Arch. Dis. Child. Fetal Neonatal Ed. 89, F367-F369. doi, 10.1136/adc.2003.032821.
13. Chiou SH, et al. 2001. Up-regulation of Fas ligand expression by human cytomegalovirus immediate-early gene product 2, a novel mechanism in cytomegalovirus-induced apoptosis in human retina. J. Immunol. 167, 4098-4103.
14. Choi J, et al. 2008. Acute respiratory distress syndrome by cytomegalovirus infection in an immunocompetent infant. Pediatr. Pulmonol. 43, 824-827.
15. Cobb LM. 1975. Growth and development of human fetal trachea and lung in immune-deprived mice. Thorax 30, 357-359.
16. Colugnati FA, Staras SA, Dollard SC, Cannon MJ. 2007. Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect. Dis. 7, 71. doi, 10.1186/1471-2334-7-71.
17. Crosby LM, et al. 2011. Balance of life and death in alveolar epithelial type II cells, proliferation, apoptosis, and the effects of cyclic stretch on wound healing. Am. J. Physiol. Lung Cell. Mol. Physiol. 301, L536-L546. doi, 10.1152/ajplung.00371.2010.
18. Crumpacker CS. 1996. Ganciclovir. N. Engl. J. Med. 335, 721-729.
19. Deimling J, et al. 2007. Mesenchymal maintenance of distal epithelial cell phenotype during late fetal lung development. Am. J. Physiol. Lung Cell. Mol. Physiol. 292, L725-L741. doi, 10.1152/ajplung.00221.2006.
20. Demmler GJ. 2003. Congenital cytomegalovirus infection treatment. Pediatr. Infect. Dis. J. 22, 1005-1006.
21. Demmler GJ, Buffone GJ, Schimbor CM, May RA. 1988. Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification. J. Infect. Dis. 158, 1177-1184.
22. Fischer C, et al. 2010. Severe postnatally acquired cytomegalovirus infection presenting with colitis, pneumonitis and sepsis-like syndrome in an extremely low birthweight infant. Neonatology 97, 339-345.
23. Fisher S, Genbacev O, Maidji E, Pereira L. 2000. Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero, implications for transmission and pathogenesis. J. Virol. 74, 6808-6820.
24. Fuchs S, et al. 2003. Differentiation of human alveolar epithelial cells in primary culture, morphological characterization and synthesis of caveolin-1 and surfactant protein-C. Cell Tissue Res. 311, 31-45.
25. Gabrielli L, et al. 2009. Histological findings in foetuses congenitally infected by cytomegalovirus. J. Clin. Virol. 46(Suppl 4), S16-S21. doi, 10.1016/j.jcv.2009.09.026.
26. Goldmacher VS, et al. 1999. A cytomegalovirus-encoded mitochondrialocalized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc. Natl. Acad. Sci. U. S. A. 96, 12536-12541.
27. Graham SM. 2003. Impact of HIV on childhood respiratory illness, differences between developing and developed countries. Pediatr. Pulmonol. 36, 462-468.
28. Grazia Revello M, et al. 2001. In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells. J. Gen. Virol. 82, 1429-1438.
29. Greene KE, et al. 1999. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am. J. Respir. Crit. Care Med. 160, 1843-1850.
30. Haastrup E, Muller K, Baekgaard H, Heilmann C. 2005. Cytomegalovirus infection after allogeneic stem cell transplant in children. Pediatr. Transplant. 9, 734-740.
31. Hamprecht K, et al. 2001. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet 357, 513-518.
32. Hansen PR, Holm AM, Svendsen UG, Olsen PS, Andersen CB. 1999. Apoptosis in acute pulmonary allograft rejection and cytomegalovirus infection. APMIS 107, 529-533.
33. Kern ER, Rybak RJ, Hartline CB, Bidanset DJ. 2001. Predictive efficacy of SCID-hu mouse models for treatment of human cytomegalovirus infections. Antivir. Chem. Chemother. 12(Suppl 1), 149-156.
34. Koklu E, Karadag A, Tunc T, Altun D, Sarici SU. 2009. Congenital cytomegalovirus infection associated with severe lung involvement in a preterm neonate, a causal relationship? Eur. J. Pediatr. 168, 1409-1412.
35. Krogerus L, Soots A, Loginov R, Bruggeman C, Lautenschlager I. 2008. CMV increases tubular apoptosis through the TNF-alpha-TNF-R1 pathway in a rat model of chronic renal allograft rejection. Transpl. Immunol. 18, 232-236.
36. Kumar ML, et al. 1984. Congenital and postnatally acquired cytomegalovirus infections, long-term follow-up. J. Pediatr. 104, 674-679.
37. Liley HG, et al. 1987. Surfactant protein of molecular weight 28,000-36,000 in cultured human fetal lung, cellular localization and effect of dexamethasone. Mol. Endocrinol. 1, 205-215.
38. Matute-Bello G, et al. 1999. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J. Immunol. 163, 2217-2225.
39. Matute-Bello G, Martin TR. 2003. Science review, apoptosis in acute lung injury. Crit. Care 7, 355-358.
40. McCune JM, et al. 1988. The SCID-hu mouse, murine model for the analysis of human hematolymphoid differentiation and function. Science 241, 1632-1639.
41. Meier J, et al. 2005. Human cytomegalovirus reactivation during lactation and mother-to-child transmission in preterm infants. J. Clin. Microbiol. 43, 1318-1324.
42. Michelson-Fiske S, Arnoult J, Febvre H. 1975. Cytomegalovirus infection of human lung epithelial cells in vitro. Intervirology 5, 354-363.
43. Mocarski ES, Bonyhadi M, Salimi S, McCune JM, Kaneshima H. 1993. Human cytomegalovirus in a SCID-hu mouse, thymic epithelial cells are prominent targets of viral replication. Proc. Natl. Acad. Sci. U. S. A. 90, 104-108. 43a.
44. Odeberg J, et al. 2006. Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells. J. Virol. 80, 8929-8939.
45. Odeberg J, et al. 2006. Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells. J. Virol. 80, 8929-8939.
46. Okulu E, et al. 2012. Severe postnatal cytomegalovirus infection with multisystem involvement in an extremely low birth weight infant. J. Perinatol. 32, 72-74.
47. Osawa R, Singh N. 2009. Cytomegalovirus infection in critically ill patients, a systematic review. Crit. Care 13, R68. doi, 10.1186/cc7875.
48. Otto WR. 2002. Lung epithelial stem cells. J. Pathol. 197, 527-535.
49. Pastva AM, Wright JR, Williams KL. 2007. Immunomodulatory roles of surfactant proteins A and D, implications in lung disease. Proc. Am. Thorac. Soc. 4, 252-257.
50. Pavlovic J, et al. 2008. Differentiation of xenografted human fetal lung parenchyma. Early Hum. Dev. 84, 181-193.
51. Piazze J, et al. 1999. The effect of primary cytomegalovirus infection on fetal lung maturity indices. Early Hum. Dev. 54, 137-144.
52. Podlech J, Holtappels R, Pahl-Seibert MF, Steffens HP, Reddehase MJ. 2000. Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation, persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection. J. Virol. 74, 7496-7507.
53. Potter EL, Loosli CG. 1951. Prenatal development of the human lung. AMA Am. J. Dis. Child. 82, 226-228.
54. Pryhuber GS, Hull WM, Fink I, McMahan MJ, Whitsett JA. 1991. Ontogeny of surfactant proteins A and B in human amniotic fluid as indices of fetal lung maturity. Pediatr. Res. 30, 597-605.
55. Radonic A, et al. 2004. Guideline to reference gene selection for quantitative real-time PCR. Biochem. Biophys. Res. Commun. 313, 856-862.
56. Reboredo M, Greaves RF, Hahn G. 2004. Human cytomegalovirus proteins encoded by UL37 exon 1 protect infected fibroblasts against virusinduced apoptosis and are required for efficient virus replication. J. Gen. Virol. 85, 3555-3567.
57. Sawyer MH, Edwards DK, Spector SA. 1987. Cytomegalovirus infection and bronchopulmonary dysplasia in premature infants. Am. J. Dis. Child. 141, 303-305.
58. Shannon JM, Hyatt BA. 2004. Epithelial-mesenchymal interactions in the developing lung. Annu. Rev. Physiol. 66, 625-645.
59. Sinzger C, Digel M, Jahn G. 2008. Cytomegalovirus cell tropism. Curr. Top. Microbiol. Immunol. 325, 63-83.
60. Sinzger C, et al. 1995. Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J. Gen. Virol. 76(Pt 4), 741-750.
61. Skaletskaya A, et al. 2001. A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc. Natl. Acad. Sci. U. S. A. 98, 7829-7834.
62. Smith MS, et al. 2010. Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model. Cell Host Microbe 8, 284-291.
63. Stagno S. 1995. Cytomegalovirus, p 312-353. In Remington JS, Klein JO (ed), Infectious diseases of the fetus and newborn infant, 4th ed. W. B. Saunders Co., Philadelphia, PA.
64. Steffens HP, Kurz S, Holtappels R, Reddehase MJ. 1998. Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence. J. Virol. 72, 1797-1804.
65. Stoddart CA, et al. 2001. Impaired replication of protease inhibitorresistant HIV-1 in human thymus. Nat. Med. 7, 712-718.
66. Takahashi R, et al. 2007. Severe postnatal cytomegalovirus infection in a very premature infant. Neonatology 92, 236-239.
67. Umashankar M, et al. 2011. A novel human cytomegalovirus locus modulates cell type-specific outcomes of infection. PLoS Pathog. 7, e1002444. doi, 10.1371/journal.ppat.1002444.
68. van Burik JA, Lawatsch EJ, DeFor TE, Weisdorf DJ. 2001. Cytomegalovirus enteritis among hematopoietic stem cell transplant recipients. Biol. Blood Marrow Transplant. 7, 674-679.
69. Vazquez de Lara L, et al. 2000. Surfactant components modulate fibroblast apoptosis and type I collagen and collagenase-1 expression. Am. J. Physiol. Lung Cell. Mol. Physiol. 279, L950-L957.
70. Vochem M, Hamprecht K, Jahn G, Speer CP. 1998. Transmission of cytomegalovirus to preterm infants through breast milk. Pediatr. Infect. Dis. J. 17, 53-58.
71. Weaver TE, Whitsett JA. 1991. Function and regulation of expression of pulmonary surfactant-associated proteins. Biochem. J. 273(Pt 2), 249-264.
72. White MK, Baireddy V, Strayer DS. 2001. Natural protection from apoptosis by surfactant protein A in type II pneumocytes. Exp. Cell Res. 263, 183-192.
73. Whitley RJ, et al. 1997. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection, results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J. Infect. Dis. 175, 1080-1086.
74. Zhu H, Shen Y, Shenk T. 1995. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J. Virol. 69, 7960-7970.